McCormack Pharma wishes to apologize for the delay in releasing its findings on the mechanism of clopidogrel resistance.

Necessarily, in updating the original report, the incorporation of additional data is taking longer than we had planned. However, in order to reduce this delay to an absolute minimum, a decision has been made to release the report in stages. The first stage will be a truncated version of the complete document, and this will be posted within a few days. This will be followed by an Introduction with a Discussion of Results, Tabulated Data, Concluding Remarks and Conflicts of Interest/Declaration of Financial Support.